Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
ADA Recommendations for GLP-1 RA in T2DM Patients The GLP-1 receptor agonists, with or without metformin based on glycemic needs, are appropriate initial therapy for patients with type 2 diabetes mellitus (T2DM) with or at high risk for atherosclerotic cardiovascular disease (ASCVD)/indicators of high-risk, heart failure (HF), or chronic kidney disease (CKD)
SGLT2 inhibitors show a strict interaction with human and murine cardiomyocytes through direct inhibition of the myocardial isoform of NHE (Uthman et al., 2018b
Novo nordisk files for regulatory approval of once-weekly semaglutide with the fda for the treatment of type 2 diabetes
The volumetric finding is a hypothesis worth testing in a powered trial with volume change as a prespecified endpoint, not a demonstration that the drug protects brain tissue
US$ 20.93
US$ 24.71
US$ 22.37
US$ 23.92
US$ 25.37
US$ 29.49
:format(webp))
US$ 27.25
US$ 28.20
US$ 27.28
